Precision Cancer Pathways are essential for patients facing rare and complex cancers because the care journey often requires specialized diagnosis, genomics-informed decision support, multidisciplinary coordination, access to research, and long-term survivorship planning.

Precision medicine is reshaping the future of healthcare, but access remains deeply unequal. “Precision Medicine for All: Breaking Barriers, Expanding Access” explores how Phronetik is redefining equitable genomics, clinical research, mobile diagnostics, and community-led innovation to ensure that every population, especially those historically left behind, has access to personalized, data-driven care.